|
|
1.
|
Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy. MedStar authors:
Year: 2017
Citation: - Journal of Cardiovascular Medicine. 18(4):283-290, 2017 Apr
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Anderson AS, Butler J, Cole RT, Epstein SE, Gheorghiade M, Greene SJ, Kim RJ, Quyyumi AA, Sikora S, Skopicki HA, Tankovich NI, Verkh L, Wilcox JE
|
|
|
2.
|
Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. MedStar authors:
- Epstein, Stephen E
- Lipinski, Michael J
Year: 2017
Citation: - Circulation Research. 120(2):332-340, 2017 Jan 20
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Anderson AS, Butler J, Cole RT, Epstein SE, Gheorghiade M, Greene SJ, Kim RJ, Ko YA, Lipinski MJ, Margulies KB, Quyyumi AA, Sikora S, Skopicki HA, Tankovich NI, Wilcox JE
|
